Susana Ursua
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: October 07, 2021
PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment.
Journal: Progress in neurobiology
Published: January 16, 2020
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Journal: ACS chemical neuroscience
Published: August 24, 2019
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
Journal: ACS chemical neuroscience
Published: December 12, 2018
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.
Journal: Molecular therapy. Nucleic acids
Published: December 10, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: December 11, 2017
Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: December 13, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: September 09, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026